U019 Prurigo Nodularis
DESCRIPTION
Open admission to eligible categories, no tuition or ticket
This session will provide a cutting-edge discussion about our current understanding of prurigo nodularis (PN), with novel insights into disease burden, pathophysiology, and emerging therapeutics, and vulnerable patient populations. This session is directed towards dermatologists and other health care providers who treat adults with prurigo nodularis.
LEARNING OBJECTIVES
Recognize the high burden of disease and comorbidities of prurigo nodularis
Identify the clinical characteristics and pathophysiology of prurigo nodularis
Describe therapeutic decision making for prurigo nodularis
SCHEDULE
8:30 PM
A New Era in Prurigo Nodularis
Shawn Kwatra, MD, FAAD
8:35 PM
What is Prurigo Nodularis?
Sarina Elmariah, MD, FAAD
8:45 PM
Updates in the Pathophysiology of Prurigo Nodularis
Shawn Kwatra, MD, FAAD
8:55 PM
Therapeutic Landscape for Prurigo Nodularis
Gil Yosipovitch, MD
9:10 PM
Communication and Management in Prurigo Nodularis
Sonja Stander, MD, IFAAD
9:20 PM
Q&A
SPEAKERS
Sarina Elmariah, MD, FAAD
Shawn Kwatra, MD, FAAD
Sonja Stander, MD, IFAAD
Gil Yosipovitch, MD
SPEAKER DISCLOSURES
Sarina Elmariah, MD, FAAD
Eli Lilly – Other(Honoraria); Galderma Laboratories, LP – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria);
Shawn Kwatra, MD, FAAD
AbbVie – Consultant(Honoraria); Amgen – Advisory Board(Honoraria); Arcutis Biotherapeutics – Advisory Board(Honoraria); Castle Biosciences, Inc – Consultant(Honoraria); Galderma – Investigator(Grants/Research Funding); Galderma USA – Consultant(Honoraria); Incyte Corporation – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Johnson and Johnson – Advisory Board(Honoraria); Leo Pharma Inc – Advisory Board(Honoraria); Novartis – Consultant(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Regeneron – Advisory Board(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding);
Sonja Stander, MD, IFAAD
AbbVie – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Almirall – Consultant(Honoraria), Investigator(Grants/Research Funding); Beiersdorf, Inc. – Consultant(Honoraria); Bellus Health – Consultant(Honoraria); BMS – Speaker(Honoraria); Cara Therapeutics – Consultant(Honoraria); Eli Lilly – Consultant (1099 relationship)(Honoraria); Galderma – Speaker(Honoraria); Galderma Laboratories, LP – Consultant(Honoraria); Galderma Research & Development, LLC – Consultant(Honoraria); Galderma USA – Investigator(Grants/Research Funding); Incyte – Consultant (1099 relationship)(Honoraria); Kiniksa Pharmaceuticals, Ltd. – Consultant(Honoraria), Investigator(Grants/Research Funding); Leo Pharma Inc – Investigator(Grants/Research Funding), Speaker(Honoraria); Novartis – Consultant(Honoraria), Speaker(Honoraria); Pfizer Inc. – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); Sanofi – Advisory Board(Honoraria), Investigator(Grants/Research Funding), Speaker(Honoraria); Sanofi Aventis – Consultant (1099 relationship)(Honoraria); Sanofi Genzyme – Consultant (1099 relationship)(Honoraria); Sanofi/Regeneron – Consultant (1099 relationship)(Honoraria); Trevi Therapeutics – Consultant(Honoraria), Investigator(Grants/Research Funding); UCB – Speaker(Honoraria); University Hospital Muenster – Advisory Board(No Compensation Received); Vifor Pharma – Consultant (1099 relationship)(Honoraria), Speaker(Honoraria); WebMD – Consultant (1099 relationship)(Honoraria);
Gil Yosipovitch, MD
AbbVie – Advisory Board(Honoraria); Arcutis, Inc. – Advisory Board(Honoraria); Cara Therapeutics – Advisory Board(Honoraria); CeraVe – Advisory Board(Honoraria); Eli Lilly – Investigator(Fees), Investigator(Grants/Research Funding); Eli Lilly and Company – Advisory Board(Honoraria); escient – Investigator(Fees), Investigator(Grants/Research Funding); Galderma – Advisory Board(Honoraria); Galderma Laboratories, L.P. – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); GSK – Advisory Board(Honoraria); Kamari Pharma – Consultant(Fees); Kiniksa Pharmaceuticals, Ltd. – Investigator(Grants/Research Funding); Maruho Co., Ltd – Speaker/Faculty Education(Fees); Novartis – Consultant(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Pierre Fabre – Consultant(Honoraria); Sanofi/Regeneron – Advisory Board(Honoraria), Investigator(Fees), Investigator(Grants/Research Funding); Vifor Pharma – Consultant(Fees);